Sign in
4

Changes in Ownership

BIOGEN INC. Filed Acc 0001127602-21-019553

Head of Research & Development sold 7,672 shares at $440.00 ($3,375,680)

From the SEC's structured data for this filing

Trades in this filing

Sandrock Alfred · Head of Research & Development

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2021-06-07 Sale : show line 1 in the form −7,672 $440.00 $3,375,680 10,169.11 D
Open-market sales · 7,672 sh · avg $440.00 · $3,375,680
Loading xslF345X03/form4.xml…